Approval · Notice of Compliance 12803 · 2011
DIFFERIN: Notice of Compliance 12803
Issued November 25, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12803
- Date
- November 25, 2011
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New Dosage Form - Lotion
- Therapeutic class
- Acne Therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIFFERIN | 02376660 | Approved |
Medicinal ingredients
- ADAPALENE 1 MG per G